Dr. Horst G. Zerbe

IntelGenx Reports Q3 2022 Financial Results, Management Anticipates Psychedelics Trials In 2023

IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) reported its financial results late Thursday for the third quarter that ended September 30, 2022.

IntelGenx Reports Third Quarter 2021 Financial Results

IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, reported financial results on Thursday afternoon for the third quarter ended September 30, 2021.